Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | ESR1 | P03372 | 2/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.38 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.38 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8960736 | 0.79 | ALDH1A1 (0.50) | ALDH1A1ALOX15HSD17B10MAPK1HPGD | |
| SCHEMBL30785388 | 0.79 | ALDH1A1 (0.50) | ALDH1A1ALOX15HSD17B10MAPK1HPGD | |
| SCHEMBL3792759 | 0.79 | MAPK1 (0.50) | ALDH1A1ALOX15HSD17B10MAPK1HPGD | |
| SCHEMBL1456970 | 0.77 | CYP3A4 (0.55) | ALDH1A1ALOX15HSD17B10MAPK1HPGD | |
| SCHEMBL525507 | 0.77 | ALDH1A1 (0.48) | ALDH1A1ALOX15HSD17B10MAPK1HPGD | |
| SCHEMBL1931084 | 0.76 | CYP3A4 (0.37) | ALDH1A1ALOX15MAPK1HPGDALOX12 | |
| SCHEMBL315655 | 0.75 | ALDH1A1 (0.46) | ALDH1A1ALOX15HSD17B10MAPK1HPGD | |
| SCHEMBL94373 | 0.75 | ALOX15 (0.46) | ALDH1A1ALOX15HSD17B10MAPK1HPGD | |
| SCHEMBL4603633 | 0.75 | ALOX15 (0.46) | ALDH1A1ALOX15HSD17B10MAPK1HPGD | |
| SCHEMBL6403160 | 0.75 | CYP3A4 (0.46) | ALDH1A1ALOX15SMN1; SMN2GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10800741-B2 | Quinoline compound, preparation method and medical use therefor | ANCUREALL PHARMACEUTICAL (SHANGHAI) CO., LTD. (CN) | 2020-10-13 | — | — | US | disclosed |
| EP-3041904-B1 | STYRYL SULFIDE DYES | BASF SE (DE) | 2020-05-20 | — | — | EP | disclosed |
| CN-110049969-A | Quinolines, preparation method and its medical usage | 恩瑞生物医药科技（上海）有限公司 | 2019-07-23 | — | — | CN | disclosed |
| EP-2606095-B1 | DISULFIDE OR THIOL POLYMERIC HAIR DYES | BASF SE (DE) | 2016-10-12 | — | — | EP | disclosed |
| EP-1890669-B1 | CATIONIC OLIGOMERIC AZO DYES | BASF SE (DE) | 2016-08-10 | — | — | EP | disclosed |
| US-20160208103-A1 | STYRYL SULFIDE DYES | BASF SE (DE) | 2016-07-21 | — | — | US | disclosed |
| EP-3041904-A1 | STYRYL SULFIDE DYES | BASF SE (DE) | 2016-07-13 | — | — | EP | disclosed |
| EP-2052034-B1 | THIOL DERIVATIVE DYES | BASF SE (DE) | 2016-06-08 | — | — | EP | disclosed |
| WO-2015059368-A1 | METHOD FOR DYEING KERATIN FIBRES USING CATIONIC STYRYL DISULPHIDE DYES, AND COMPOSITION INCLUDING SAID DYES | L'OREAL (FR) | 2015-04-30 | — | — | WO | disclosed |
| WO-2015028543-A1 | STYRYL SULFIDE DYES | BASF SE (DE) | 2015-03-05 | — | — | WO | disclosed |
| US-20040158937-A1 | Cationic substituted hydrazone dyes | CIBA SPECIALTY CHEMICALS CORP. | 2004-08-19 | — | — | US | disclosed |
| EP-1438006-A1 | METHOD OF COLOURING KERATIN-CONTAINING FIBRES USING DIAZONIUM SALTS | Ciba SC Holding AG (CH) | 2004-07-21 | — | — | EP | disclosed |
| EP-1430102-A1 | CATIONIC REACTIVE DYES | Ciba SC Holding AG (CH) | 2004-06-23 | — | — | EP | disclosed |
| WO-2004019896-A1 | METHOD OF COLOURING POROUS MATERIAL | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-03-11 | — | — | WO | disclosed |
| WO-2004019897-A1 | METHOD OF COLOURING POROUS MATERIAL | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-03-11 | — | — | WO | disclosed |
| WO-2003076518-A2 | PROCESS FOR EXCHANGING THE ANIONS OF CATIONIC COMPOUNDS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-09-18 | — | — | WO | disclosed |
| WO-2003070207-A1 | METHOD OF COLOURING KERATIN-CONTAINING FIBRES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-08-28 | — | — | WO | disclosed |
| WO-2003060015-A1 | YELLOW CATIONIC DYES FOR DYING OF ORGANIC MATERIAL | CIBA SPECIALITY CHEMICALS HOLDING INC. (CH) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003032939-A1 | METHOD OF COLOURING KERATIN-CONTAINING FIBRES USING DIAZONIUM SALTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-04-24 | — | — | WO | disclosed |
| WO-2003029359-A1 | CATIONIC REACTIVE DYES | CIBA SPECIALTY CHEMICALS HOLDINGS INC. (CH) | 2003-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160208103-A1 | STYRYL SULFIDE DYES | C1R, C1S, C5 | ALDH1A1 917/4885ALOX15 692/4885HSD17B10 1905/4885 |
| US-20040158937-A1 | Cationic substituted hydrazone dyes | KRT18, CYC1, COL1A1 | ALDH1A1 1049/4885ALOX15 3441/4885HSD17B10 1162/4885 |
| US-10800741-B2 | Quinoline compound, preparation method and medical use therefor | WEE2, WEE1, HASPIN | ALDH1A1 1958/4885ALOX15 1705/4885HSD17B10 2930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.